SCHEMBL945923

SCHEMBL945923

COc1ccc(C2(C3CC3)N=C(C)C(=S)N2)cc1Br

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
POLB P06746 3/20 0.34
TP53 P04637 2/20 0.34
PKM P14618 1/20 0.33
MAPK1 P28482 2/20 0.33
APOBEC3G Q9HC16 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
ADAM17 P78536 1/20 0.32
MAPT P10636 3/20 0.32
DBH P09172 1/20 0.32
MCOLN3 Q8TDD5 1/20 0.32
THRB P10828 1/20 0.31
HDAC1 Q13547 1/20 0.31
PDE2A O00408 1/20 0.31
GFER P55789 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL945249 0.78 CHRNA1 (0.37) ALDH1A1MAPK1APOBEC3G
SCHEMBL932692 0.74 BACE1 (0.42) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL945955 0.74 BACE1 (0.42) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL945139 0.74 BACE1 (0.42) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL931601 0.71 BACE1 (0.50) ALDH1A1PKM
SCHEMBL18927239 0.68 LMNA (0.33) ALDH1A1PKMLMNA
SCHEMBL28510872 0.64 ALDH1A1 (0.46) ALDH1A1KDM4EPOLBMAPK1KMT2A
SCHEMBL6920536 0.64 BACE1 (0.39) ALDH1A1KDM4EGAAPKMKMT2A
SCHEMBL20790232 0.63 MAOA (0.42) ALDH1A1KDM4EGAAPOLBPKM
SCHEMBL28829926 0.62 ALDH1A1 (0.44) ALDH1A1KDM4EMAPK1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed